January 2024 - We are delighted to share some significant and positive changes happening within the governance of the iCMLf that promise to further enhance our mission and impact to improve the lives of patients living with CML worldwide.

Please join us in welcoming the following people as we continue to expand and diversify our Board of Directors, Advisory Committees and the Operational Team.

New Chairman of the Board: Professor Jorge Cortes

In late 2023, the iCMLf embarked on a new chapter with Professor Jorge Cortes as iCMLf Chairman. With his wealth of experience, he brings valuable insights and leadership to guide the iCMLf over the next years in its on-going mission to improve outcomes for people with CML globally.

View Professor Jorge Cortes talking about his vision for the iCMLf here
Learn more about the new Chairman of the iCMLf here
View an interview with our past and present iCMLf Chairs on why they formed the iCMLf here

New Members of the iCMLf Board of Directors: Professor Hemant Malhotra and Dr Katia Pagnano

Joining our esteemed Board of Directors, are Professor Hemant Malhotra, from Jaipur, India and Dr Katia Pagnano from Campinas, Brazil. The broad expertise in CML from these two hematologists will bring critical perspectives from low- and middle-income countries at the Board level of the iCMLf. Their contribution to the strategic vision and governance of the Foundation will further our diverse and global representation, reach and impact.

Learn more about Professor Hemant Malhotra here
Learn more about Dr Katia Pagnano here

Scientific Advisory Committee Expansion: Professor Ehab Atallah

We are excited to welcome Professor Ehab Atallah from Milwaukee, USA to our Scientific Advisory Board. Professor Atallah is a long-standing collaborator with the iCMLf in various programs and his commitment and experience will further strenghten our ability to advance CML research and innovation.

Learn more about Dr Ehab Atallah here

Newly launched Patient Advisory Committee

Close consultation and cooperation with CML Patient Advocacy groups has always been part of the iCMLf’s guiding principles. A newly launched iCMLf Patient Advisory Committee (PAC) aims to bring CML patients’ perspective to the forefront of the Foundation by providing patient centric advice to our educational and research programs, along with future strategies and priorities.

More information about the charter and the members of the PAC will follow soon.

New Communications Manager: Sarah Swaroop

Introducing Sarah Swaroop (Glasgow, UK), our new iCMLf Communications Manager. Sarah brings over 15 years of experience in marketing, campaign development and strategic communications. Her work with the iCMLf will help to further grow our audience and share the Foundation’s programs and fundraising.

These additions to our governance and operational teams mark an exciting new chapter for the iCMLf. It’s only through the active engagement of the CML community around the world that the iCMLf will achieve our goals and we extend our gratitude to everyone involved making this happen.